Clinical Analysis of Uncommon Epidermal Growth Factor Receptor Mutations in 16 Cases of Nonsmall Cell Lung Cancer

被引：1
|
作者：
Hu, Ai-Min [1 ]
Li, Yun-Song [2 ]
Zhao, Dan [3 ]
Hu, Fan-Bin [1 ]
Wang, Qun-Hui [1 ]
Li, Bao-Lan [1 ]
机构：
[1] Capital Med Univ, Beijing TB & Thorac Tumor Res Inst, Beijing Chest Hosp, Dept Oncol, Beijing 101149, Peoples R China
[2] Capital Med Univ, Beijing TB & Thorac Tumor Res Inst, Beijing Chest Hosp, Dept Thorac Surg, Beijing 101149, Peoples R China
[3] Capital Med Univ, Beijing TB & Thorac Tumor Res Inst, Beijing Chest Hosp, Dept Pathol, Beijing 101149, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2018年 / 131卷 / 08期
关键词：
D O I：
10.4103/0366-6999.229887
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1005 / 1006
页数：2
相关论文
共 50 条
  • [31] Accuracy of epidermal growth factor receptor mutation analysis on the basis of small biopsy specimens in patients with nonsmall cell lung cancer
    Fujita, Shiro
    Mio, Tadashi
    Sonobe, Makoto
    Kamiyama, Kiyofumi
    Masago, Katsuhiro
    Miyahara, Ryo
    Wada, Hiromi
    Mishima, Michiaki
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (07) : 1751 - 1752
  • [32] The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal
    Gristina, Valerio
    Malapelle, Umberto
    Galvano, Antonio
    Pisapia, Pasquale
    Pepe, Francesco
    Rolfo, Christian
    Tortorici, Silvia
    Bazan, Viviana
    Troncone, Giancarlo
    Russo, Antonio
    CANCER TREATMENT REVIEWS, 2020, 85
  • [33] Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
    Frega, Stefano
    Lorenzi, Martina
    Fassan, Matteo
    Indraccolo, Stefano
    Calabrese, Fiorella
    Favaretto, Adolfo
    Bonanno, Laura
    Polo, Valentina
    Zago, Giulia
    Lunardi, Francesca
    Attili, Ilaria
    Pavan, Alberto
    Rugge, Massimo
    Guarneri, Valentina
    Conte, PierFranco
    Pasello, Giulia
    ONCOTARGET, 2017, 8 (20) : 32626 - 32638
  • [34] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Yan Zhang
    Zheng Wang
    Xuezhi Hao
    Xingsheng Hu
    Hongyu Wang
    Yan Wang
    Jianming Ying
    ChineseJournalofCancerResearch, 2017, 29 (01) : 18 - 24
  • [35] The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary Diseases
    Usui, Kazuhiro
    Ushijima, Tomonori
    Tanaka, Yoshiaki
    Tanai, Chiharu
    Noda, Hiromichi
    Abe, Norifumi
    Horiuchi, Hajime
    Ishihara, Teruo
    PULMONARY MEDICINE, 2011, 2011
  • [36] Depression and inflammation among epidermal growth factor receptor (EGFR) mutant nonsmall cell lung cancer patients
    McFarland, Daniel C.
    Jutagir, Devika R.
    Rosenfeld, Barry
    Pirl, William
    Miller, Andrew H.
    Breitbart, William
    Nelson, Christian
    PSYCHO-ONCOLOGY, 2019, 28 (07) : 1461 - 1469
  • [37] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Zhang, Yan
    Wang, Zheng
    Hao, Xuezhi
    Hu, Xingsheng
    Wang, Hongyu
    Wang, Yan
    Ying, Jianming
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (01) : 18 - 24
  • [38] Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)
    Kunihiko Kobayashi
    Koichi Hagiwara
    Targeted Oncology, 2013, 8 : 27 - 33
  • [39] Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)
    Kobayashi, Kunihiko
    Hagiwara, Koichi
    TARGETED ONCOLOGY, 2013, 8 (01) : 27 - 33
  • [40] Targeted therapy for nonsmall cell lung cancer: focusing on angiogenesis, the epidermal growth factor receptor and multikinase inhibitors
    Kotteas, Elias A.
    Charpidou, Andriani G.
    Syrigos, Kostas N.
    ANTI-CANCER DRUGS, 2010, 21 (02) : 151 - 168
12345